United States · FDA National Drug Code directory
SAPHNELO
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0310-3080_810dc1a8-73e1-41fc-874f-2dd1d8ed1429
- Product NDC
- 0310-3080
- Form
- INJECTION, SOLUTION
- Composition / generic term
- Anifrolumab-fnia
- Labeler
- AstraZeneca Pharmaceuticals LP
- Marketing category
- BLA
- Marketing start / end (source format)
- 20260424
- Source listing expiry
- 20271231
Source-listed ingredients
- ANIFROLUMAB — 120 mg/.8mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 SYRINGE, GLASS in 1 CARTON (0310-3080-01) / .8 mL in 1 SYRINGE, GLASS (0310-3080-25) · 0310-3080-01
- 1 SYRINGE, GLASS in 1 CARTON (0310-3080-02) / .8 mL in 1 SYRINGE, GLASS (0310-3080-75) · 0310-3080-02
- 1 SYRINGE, GLASS in 1 CARTON (0310-3080-95) / .8 mL in 1 SYRINGE, GLASS (0310-3080-25) · 0310-3080-95
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →